IVF (In Vitro Fertilization) has helped many couples overcome infertility challenges, but success rates can vary due to genetic factors. Preimplantation Genetic Testing for Aneuploidy (PGT-A) is an advanced screening method that enhances the chances of a successful pregnancy by identifying embryos with the correct number of chromosomes. This reduces the risk of miscarriage and increases the likelihood of a healthy baby. In Dubai, where medical advancements in reproductive health are rapidly progressing, PGT-A is becoming an integral part of many IVF treatment plans.
PGT-A is a specialized genetic screening process used during IVF to examine embryos for chromosomal abnormalities before implantation. Chromosomes carry genetic material that determines a baby’s health and development. An embryo with an incorrect number of chromosomes (aneuploidy) may result in implantation failure, miscarriage, or genetic disorders such as Down syndrome. During PGT-A, a few cells are carefully biopsied from the embryo at the blastocyst stage (usually on the fifth or sixth day of development). These cells are then analyzed in a laboratory to determine whether the embryo has the correct number of chromosomes. Only chromosomally normal embryos are selected for implantation, improving the chances of a successful pregnancy and reducing the risk of genetic conditions.
One of the most significant benefits of PGT-A is its ability to improve IVF success rates. Traditional IVF relies on selecting embryos based on their appearance under a microscope. However, even visually healthy embryos can have chromosomal abnormalities that may prevent successful implantation or lead to early pregnancy loss. PGT-A helps identify and transfer only genetically viable embryos, increasing the chances of implantation and reducing the risk of miscarriage. Studies have shown that PGT-A can significantly boost the success of IVF cycles, particularly for women of advanced maternal age. A woman's chances of chromosomal abnormalities in her eggs rises as she ages, which reduces pregnancy rates and raises miscarriage rates. Many couples in Dubai looking for fertility treatments choose PGT-A because it can improve the success of IVF by screening embryos before implantation.
PGT-A is beneficial for a wide range of patients undergoing IVF. While it is not a mandatory part of the process, it is often recommended for individuals and couples facing specific reproductive challenges. Those who may benefit from PGT-A include:
The IVF process combined with PGT-A follows several key steps to ensure the best possible outcome for the intended parents. Here’s a breakdown of how the process works:
Selecting the right IVF clinic is crucial for a successful treatment experience. When considering an IVF clinic in Dubai that offers PGT-A, prospective parents should evaluate several factors:
For couples and others looking to raise their chances of a healthy pregnancy, IVF with PGT-A in Dubai presents a viable answer. PGT-A improves IVF success rates, lowers the risk of miscarriage, and gives parents-to- be piece of mind by spotting chromosomally normal embryos before implantation. Although PGT-A is not required for everyone, for those with a history of infertility, repeated miscarriages, or genetic concerns it is a useful tool. To get the best results, one must select a respectable IVF clinic experienced in PGT-A. Couples have access to state-of-the-art reproductive technologies thanks to Dubai's sophisticated medical facilities and seasoned fertility experts, so realizing their dreams of parenthood. Prospective parents who know the advantages and PGT-A process can make wise decisions and start their fertility path with assurance.
Schedule a consultation with our expert team at MMC IVF. We are here to provide personalized care and support
MMCIVF & Zivanza Wellness - Brands of Millennium Medical Center LLC, DET License No. 814420 & DHA Facility License No. 0002527
MMCIVF operates under the laws, rules and regulations of the United Arab Emirates and the Emirate of Dubai. All patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMC IVF and / or MMCIVF Directors and / or MMCIVF Doctors and / or MMCIVF Nurses and / or MMCIVF Staff and / or MMCIVF Agents are expected to be fully compliant with the laws, rules and regulations in the United Arab Emirates and the Emirate of Dubai and of any other jurisdiction they (the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMC IVF and / or MMCIVF Directors and / or MMCIVF Doctors and / or MMCIVF Nurses and / or MMCIVF Staff and / or MMCIVF Agents) are subject to. MMCIVF / MMCIVF Directors / MMCIVF Doctors / MMCIVF Nurses / MMCIVF Staff / MMCIVF Agents cannot and will not take any responsibility and / or liability for compliance or non-compliance of any law, rule or regulation outside the United Arab Emirates which is solely the responsibility of the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMC IVF and / or MMCIVF Directors and / or MMCIVF Doctors and / or MMCIVF Nurses and / or MMCIVF Staff and / or MMCIVF Agents.
Further, MMCIVF and / or MMC IVF Directors and / or MMCIVF Doctors and / or MMCIVF Nurses and / or MMCIVF Staff and / or MMCIVF Agents will not solicit and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India to Indian Citizens / Residents (whether in India or outside India) strictly following this as MMCIVF policy recognizing and respecting applicable Indian Laws, Rules, and Regulations. All Indian Citizens / Residents are advised to ensure that they fully comply with the applicable Indian Laws, Rules, and Regulations while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF. MMCIVF shall not take any responsibility whatsoever for any violation of any applicable Indian Laws, Rules, and Regulations by any Indian Citizen / Resident while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF which sole responsibility shall vest with such Indian Citizens / Residents reaching out / interacting / communicating / consulting / taking treatment with MMCIVF. In case any individual / agency / firm / company reaches out to any Indian Citizen / Resident for and on behalf of MMCIVF for any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India, please be known that we have not authorized any staff member / individual / agency / firm / company to reach out to Indian Citizens / Residents (whether in India or outside India) to offer and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India. If you are aware of any such reach outs and / communication, please inform MMCIVF at info@mmcivf.com immediately so that we can take remedial measures against such reach outs claiming to represent MMCIVF.
MMCIVF is the trade mark and trade name of MMC Millennium Medical Center LLC., Dubai, United Arab Emirates.
MMC IVF, UAE, strictly adheres to all IVF and Surrogacy rules and regulations applicable in the UAE. While we may share general information about IVF and Surrogacy with visitors to our websites, we will proceed with treatment to any patient in the UAE only in full compliance with the applicable legal and regulatory framework governing IVF and Surrogacy in UAE.
Further, MMCIVF UAE operates independently and separately from other MMCIVF Clinics in countries other than the UAE.